Corcept Therapeutics Incorporated (CORT) has a market capitalization of $4.65B and trades at $43.68. The 52-week range is 28.66-91.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 46, Earnings Per Share (EPS) of $0.95, annual revenue of $761.41M.
The stock has a beta of 0.25, operates in the Healthcare sector.
